Company CVAbout Smruthi Organics Ltd 
Smruthi Organics Ltd
Micro Cap
Pharmaceuticals & Drugs
Smruthi Organics Limited was incorporated in July, 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February, 1995. The Company was promoted by E Purushotham and Shankarrao R Myakal.
Company Coordinates
Company Details
165-A Balaji Bhavan 1st Floor, Railway Lines Solapur Maharashtra : 413001
Registrar Details
Adroit Corporate Services Pvt Ltd, 17-20 Jaferbhoy Industrial Estate , 1st Floor, Makwana Road, Marol Naka, Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 11.45 Cr
Number of Shares
1.14 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
16-Mar-2021
1.14
11.45
7630860
10
Bonus Issue
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Eaga Purushotham Malaiah (41.23%)
Highest Public shareholder
None
Individual Investors Holdings
28.83%
Board of Directors
Management
Designation
Remuneration
E Purushotham
Chairman & Managing Director
2.11 cr
E Swapnil
Joint Managing Director & CFO
1.44 cr
J H Ranade
Independent Director
2.05 lacs
K Ramaswamy
Independent Director
2.05 lacs
Kashinath R Dhole
Independent Director
1.9 lacs
Urvashi D Khanna
Company Sec. & Compli. Officer
0
E. Smruthi
Non-Exec & Non-Independent Dir
80.0 k
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Bulk Drugs & Drug Intermediates
135.39
98.53%
Other Operating Income - Export Incentive on Focus Marketing Scheme (FMS)
1.29
0.94%
Other Operating Income - Duty Draw Back
0.73
0.53%
Bulk Drugs & Drug Intermediates
Bulk Drugs & Drug Intermediates
Other Operating Income - Export Incentive on Focus Marketing Scheme (FMS)
Other Operating Income - Export Incentive on Focus Marketing Scheme (FMS)
Other Operating Income - Duty Draw Back
Other Operating Income - Duty Draw Back
Stock DNARevenue and Profits:
Net Sales:
31 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
Pharmaceuticals & Drugs
INR 134 Cr (Micro Cap)
47.00
33
1.28%
0.24
4.22%
1.98
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
